Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
February 14, 2022
Trends and Characteristics of Global Initiative for Chronic Obstructive Lung Disease Guidelines-Discordant Prescribing of Triple Therapy Among Patients with COPD
Surya P Bhatt, Cori Blauer-Peterson, Erin K Buysman, et al.
Journal of Managed Care & Specialty Pharmacy
|
July 18, 2020
Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy
Swetha R Palli, Monica Frazer, Mary DuCharme, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
February 19, 2025
Clinical and Economic Evaluation of Fluticasone Furoate/Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol Therapy in Maintenance Treatment-Naive Patients with COPD in the US
Asif Shaikh, John Ritz, Julian Casciano, et al.
Journal of Comparative Effectiveness Research
|
April 5, 2017
The economic value of rapid deployment aortic valve replacement via full sternotomy
Matt Moore, Glenn R Barnhart, W Randolph Chitwood, et al.
Journal of Medical Economics
|
August 24, 2016
The economic value of INTUITY in aortic valve replacement
Matthew Moore, Glenn R Barnhart, Walter Randolph Chitwood, et al.
Journal of Medical Economics
|
December 12, 2017
The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty
Eric Keuffel, Peter A McCullough, Thomas M Todoran, et al.
American Health & Drug Benefits
|
May 4, 2017
Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use
Qing Huang, Michael Grabner, Robert J Sanchez, et al.
Journal of Comparative Effectiveness Research
|
October 27, 2017
Hospital cost impact of orbital atherectomy with angioplasty for critical limb ischemia treatment: a modeling approach
Nicolas W Shammas, Christopher W Boyes, Swetha R Palli, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 3, 2023
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol
Sanjay Sethi, Swetha R Palli, Lindsay G S Bengtson, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 27, 2023
Real-world impact of empagliflozin on total cost of care in adults with type 2 diabetes: Results from an outcomes-based agreement
Samuel K Peasah, Yan Huang, Swetha R Palli, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
February 14, 2022
Trends and Characteristics of Global Initiative for Chronic Obstructive Lung Disease Guidelines-Discordant Prescribing of Triple Therapy Among Patients with COPD
Surya P Bhatt, Cori Blauer-Peterson, Erin K Buysman, et al.
Journal of Managed Care & Specialty Pharmacy
|
July 18, 2020
Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy
Swetha R Palli, Monica Frazer, Mary DuCharme, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
February 19, 2025
Clinical and Economic Evaluation of Fluticasone Furoate/Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol Therapy in Maintenance Treatment-Naive Patients with COPD in the US
Asif Shaikh, John Ritz, Julian Casciano, et al.
Journal of Comparative Effectiveness Research
|
April 5, 2017
The economic value of rapid deployment aortic valve replacement via full sternotomy
Matt Moore, Glenn R Barnhart, W Randolph Chitwood, et al.
Journal of Medical Economics
|
August 24, 2016
The economic value of INTUITY in aortic valve replacement
Matthew Moore, Glenn R Barnhart, Walter Randolph Chitwood, et al.
Journal of Medical Economics
|
December 12, 2017
The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty
Eric Keuffel, Peter A McCullough, Thomas M Todoran, et al.
American Health & Drug Benefits
|
May 4, 2017
Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use
Qing Huang, Michael Grabner, Robert J Sanchez, et al.
Journal of Comparative Effectiveness Research
|
October 27, 2017
Hospital cost impact of orbital atherectomy with angioplasty for critical limb ischemia treatment: a modeling approach
Nicolas W Shammas, Christopher W Boyes, Swetha R Palli, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 3, 2023
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol
Sanjay Sethi, Swetha R Palli, Lindsay G S Bengtson, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 27, 2023
Real-world impact of empagliflozin on total cost of care in adults with type 2 diabetes: Results from an outcomes-based agreement
Samuel K Peasah, Yan Huang, Swetha R Palli, et al.
Page
of 3